Beschreibung:
<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Depression is an important sequela in critically ill patients. However, its prevalence after extracorporeal membrane oxygenation (ECMO) therapy and its association with long‐term mortality remain controversial.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Data were extracted from the South Korean National Health Insurance Service database in this population‐based cohort study. Adults who received ECMO therapy from 2006 to 2014 were included. Survivors of ECMO were defined as patients who underwent ECMO and survived over 365 days after the initiation of ECMO therapy.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A total of 3,055 survivors of ECMO were included in the final analysis. They were classified into the pre‐ECMO depression group (<jats:italic>n</jats:italic> = 275 [9.0%]), post‐ECMO depression group (<jats:italic>n</jats:italic> = 331 [10.8%]), and other ECMO survivor group. In the multivariable Cox regression model, a 1.52‐fold higher mortality was observed in the post‐ECMO depression group than in the other groups (hazard ratio, 1.52; 95% confidence interval, 1.17–1.96;<jats:italic>p</jats:italic> = .002). However, there was no statistically significant difference between the pre‐ECMO depression group and the other groups (<jats:italic>p</jats:italic> = .075).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The prevalence of pre‐ and post‐ECMO depression was 9.0% and 10.8%, respectively. Additionally, post‐ECMO depression was associated with an increased 5 year all‐cause mortality; however, pre‐ECMO depression was not.</jats:p></jats:sec>